People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Manufacturing, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Renmatix, Inc. | — | Manufacturing | Series C | $141.3M | $550.4M | 2011 |
| ARZEDA Corp. | — | Other | Series B | $82.9M | $21.0M | 2020 |
| DMC Biotechnologies, Inc. | — | Biotechnology | Series B | $48.1M | $5.4M | 2025 |
| Bioformix Inc. | — | Other | Series A | $47.0M | $75.7M | 2011 |
| Trelys, Inc. | — | Biotechnology | Seed | $2.5M | $111.0M | 2013 |
Doug Cameron at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Doug Cameron on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Smith | 1 | 17 |
| Kristina Burow | 1 | 16 |
| JOHN DOERR | 1 | 14 |
| Larry Page | 1 | 10 |
| Thomas Erickson | 1 | 7 |
| John Trbovich | 1 | 7 |
| Tim Brown | 1 | 7 |
| William Lese | 1 | 6 |
| John Habbert | 1 | 5 |
| Michael Hamilton | 1 | 5 |
| Brook Porter | 1 | 4 |
| John Melo | 1 | 3 |
| Jay Kouba | 1 | 3 |
| Alan Barton | 1 | 3 |
| Adam Malofsky | 1 | 3 |
| Robert Pangborn | 1 | 3 |
| Jennifer Miller | 1 | 3 |
| Ajit Nazre | 1 | 3 |
| Alastair Cooper | 1 | 3 |
| Jeff Klunzinger | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.